• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Infographic: Biosimilar Substitution Laws By State

Article

Currently, 29 US states and Puerto Rico have passed laws allowing pharmacists to substitute biosimilars in place of a name-brand biologic drug. However, not all biosimilars laws are created alike: some require patients to be notified of the substitution, and some dictate that any substitutions must be for the lowest-cost drug.

To learn more about biosimilars legislation and which state could be next to pass such a law, see the infographic here.

Newsletter

Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.

Recent Videos
Elie Bahou, MD, PhD
Steve Pickette, PharmD
global biosimilars week join the movement
© 2025 MJH Life Sciences

All rights reserved.